Zeposia 0.92 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB26FWRL6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,621
Award facts
- Contract value 100% obligated
- $4,620.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $4,620.94 firm fixed-price delivery order on October 21, 2025, for Zeposia 0.92 mg capsules (30-count units). This is a non-set-aside award with an ultimate completion date of November 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a relatively modest transaction within the company's broader federal pharmaceutical supply portfolio, which primarily serves military and veteran healthcare systems.
This award is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs. Zeposia is a specialty neurological medication, consistent with AmerisourceBergen Drug Corp's demonstrated capability to deliver specialized pharmaceutical products across multiple therapeutic domains. The company competes in an open market for DLA medical supply contracts and is positioned as a primary vendor for federal medical procurement needs across multiple government healthcare systems, including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB26FWRL6?
SPE2DB26FWRL6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DB26FWRL6 worth?
The government has obligated $4,621 on SPE2DB26FWRL6.
Is contract SPE2DB26FWRL6 an order under another contract?
Yes. SPE2DB26FWRL6 is a delivery order under SPE2DB24D2018, an indefinite delivery contract.
Was contract SPE2DB26FWRL6 competed?
The extent of competition for SPE2DB26FWRL6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award